Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Exchange Rate Effect (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Exchange Rate Effect for 15 consecutive years, with $165000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect fell 96.97% to $165000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$3.6 million, a 177.18% decrease, with the full-year FY2024 number at -$6.2 million, down 147.42% from a year prior.
  • Exchange Rate Effect was $165000.0 for Q3 2025 at Usana Health Sciences, down from $2.3 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $5.4 million in Q3 2024 to a low of -$9.2 million in Q4 2022.
  • A 5-year average of -$1.3 million and a median of -$584000.0 in 2022 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: skyrocketed 772.09% in 2022, then plummeted 582.15% in 2024.
  • Usana Health Sciences' Exchange Rate Effect stood at -$2.0 million in 2021, then skyrocketed by 300.05% to $3.9 million in 2022, then rose by 3.54% to $4.1 million in 2023, then plummeted by 267.57% to -$6.8 million in 2024, then soared by 102.42% to $165000.0 in 2025.
  • Per Business Quant, the three most recent readings for USNA's Exchange Rate Effect are $165000.0 (Q3 2025), $2.3 million (Q2 2025), and $719000.0 (Q1 2025).